Cargando…
Cancer vaccines: what’s next?
Autores principales: | Depil, Stéphane, Bonaventura, Paola, Alcazer, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592285/ https://www.ncbi.nlm.nih.gov/pubmed/31258838 http://dx.doi.org/10.18632/oncotarget.27006 |
Ejemplares similares
-
Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers
por: Alcazer, Vincent, et al.
Publicado: (2020) -
Cold Tumors: A Therapeutic Challenge for Immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2019) -
Cancer vaccines at an inflexion point: what next?
por: Bot, Adrian, et al.
Publicado: (2011) -
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2022) -
What Next
Publicado: (1889)